THE ENTERAL RESUSCITATION IN INTENSIVE CARE STUDY

Medizinische Universität Wien, klinische Abteilung für Nephrologie und Dialyse0 个研究点目标入组 64 人开始时间: 2018年7月10日最近更新: 2021年8月10日

试验速览

暂无简介。

•(1) Newly intubated patients (<72h)
•(2) Age >18 years
•(3) Amount of fluid substitution was within the range as defined for the respective disease per Table 2 in clinical study protocol
•(4) Negative pregnancy test in female patients of childbearing potential
•(5) Informed consent
•(6) Expected required fluid volume may not exceed 4 mL/kg/h (permanently, during at least 24 hours)
•(7) For patients that are temporarily unable to consent a subsequent informed consent has to be provided.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 32
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 32

•(1) Evidence of severe gastrointestinal disease defined as:
•- Gastrointestinal Failure score > 3 or
•- lactate >3mmol/L when mesenterial ischemia is a probable cause or
•- intraabdominal pressure >20mmHg or increase under enteral fluid/nutrition administration)
•(2) Patients who cannot receive early enteral nutrition due to conditions such as prone positioning in consequence of conditions such as acute respiratory distress syndrome
•(3) Pregnancy
•(4) Abdominal surgery in the last 3 months (unless all involved physicians – study investigators and caretaking doctors – agree that the surgical event does not constitute a limitation for enteral fluid administration)
•(5) Postoperative patients
•(6) At the discretion of the Investigator

发起方

Medizinische Universität Wien, klinische Abteilung für Nephrologie und Dialyse